{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:29:54Z","timestamp":1707524994404},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,18]]},"DOI":"10.7759\/cureus.37746","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T08:34:27Z","timestamp":1681806867000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Hypoparathyroidism in Type 1 Diabetes Mellitus"],"prefix":"10.7759","author":[{"given":"Namra V","family":"Gohil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aasvi V","family":"Gohil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.55","article-title":"Hypoparathyroidism","volume":"3","author":"Mannstadt M","year":"2017","unstructured":"Mannstadt M, Bilezikian JP, Thakker RV, et al.. Hypoparathyroidism. Nat Rev Dis Primers. 2017, 3:17055. 10.1038\/nrdp.2017.55","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3909","article-title":"Presentation of hypoparathyroidism: etiologies and clinical features","volume":"101","author":"Shoback DM","year":"2016","unstructured":"Shoback DM, Bilezikian JP, Costa AG, et al.. Presentation of hypoparathyroidism: etiologies and clinical features. J Clin Endocrinol Metab. 2016, 101:2300-12. 10.1210\/jc.2015-3909","journal-title":"J Clin Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3908","article-title":"Epidemiology and diagnosis of hypoparathyroidism","volume":"101","author":"Clarke BL","year":"2016","unstructured":"Clarke BL, Brown EM, Collins MT, et al.. Epidemiology and diagnosis of hypoparathyroidism. J Clin Endocrinol Metab. 2016, 101:2284-99. 10.1210\/jc.2015-3908","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0b013e32835a255c","article-title":"An update on the clinical and molecular characteristics of pseudohypoparathyroidism","volume":"19","author":"Levine MA","year":"2012","unstructured":"Levine MA. An update on the clinical and molecular characteristics of pseudohypoparathyroidism. Curr Opin Endocrinol Diabetes Obes. 2012, 19:443-51. 10.1097\/MED.0b013e32835a255c","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/humu.21489","article-title":"Functional characterization of GNAS mutations found in patients with pseudohypoparathyroidism type Ic defines a new subgroup of pseudohypoparathyroidism affecting selectively Gs\u03b1-receptor interaction","volume":"32","author":"Thiele S","year":"2011","unstructured":"Thiele S, de Sanctis L, Werner R, et al.. Functional characterization of GNAS mutations found in patients with pseudohypoparathyroidism type Ic defines a new subgroup of pseudohypoparathyroidism affecting selectively Gs\u03b1-receptor interaction. Hum Mutat. 2011, 32:653-60. 10.1002\/humu.21489","journal-title":"Hum Mutat"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2014.07.025","article-title":"Heterozygous mutations in cyclic AMP phosphodiesterase-4D (PDE4D) and protein kinase A (PKA) provide new insights into the molecular pathology of acrodysostosis","volume":"26","author":"Kaname T","year":"2014","unstructured":"Kaname T, Ki CS, Niikawa N, et al.. Heterozygous mutations in cyclic AMP phosphodiesterase-4D (PDE4D) and protein kinase A (PKA) provide new insights into the molecular pathology of acrodysostosis. Cell Signal. 2014, 26:2446-59. 10.1016\/j.cellsig.2014.07.025","journal-title":"Cell Signal"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1048","article-title":"Clinical review: pseudohypoparathyroidism: diagnosis and treatment","volume":"96","author":"Mantovani G","year":"2011","unstructured":"Mantovani G. Clinical review: pseudohypoparathyroidism: diagnosis and treatment. J Clin Endocrinol Metab. 2011, 96:3020-30. 10.1210\/jc.2011-1048","journal-title":"J Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa113","article-title":"Hypoparathyroidism","volume":"105","author":"Bilezikian JP","year":"2020","unstructured":"Bilezikian JP. Hypoparathyroidism. J Clin Endocrinol Metab. 2020, 105:1722-36. 10.1210\/clinem\/dgaa113","journal-title":"J Clin Endocrinol Metab"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3907","article-title":"Management of hypoparathyroidism: summary statement and guidelines","volume":"101","author":"Brandi ML","year":"2016","unstructured":"Brandi ML, Bilezikian JP, Shoback D, et al.. Management of hypoparathyroidism: summary statement and guidelines. J Clin Endocrinol Metab. 2016, 101:2273-83. 10.1210\/jc.2015-3907","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/150069-a-case-of-hypoparathyroidism-in-type-1-diabetes-mellitus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:00:38Z","timestamp":1707508838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/150069-a-case-of-hypoparathyroidism-in-type-1-diabetes-mellitus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,18]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.37746","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,18]]}}}